Loading…
Acidotoxicity and acid-sensing ion channels contribute to motoneuron degeneration
Amyotrophic lateral sclerosis (ALS) is a fatal neurological condition with no cure. Mitochondrial dysfunction, Ca 2+ overloading and local hypoxic/ischemic environments have been implicated in the pathophysiology of ALS and are conditions that may initiate metabolic acidosis in the affected tissue....
Saved in:
Published in: | Cell death and differentiation 2013-04, Vol.20 (4), p.589-598 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Amyotrophic lateral sclerosis (ALS) is a fatal neurological condition with no cure. Mitochondrial dysfunction, Ca
2+
overloading
and
local hypoxic/ischemic environments have been implicated in the pathophysiology of ALS and are conditions that may initiate metabolic acidosis in the affected tissue. We tested the hypothesis that acidotoxicity and acid-sensing ion channels (ASICs) are involved in the pathophysiology of ALS. We found that motoneurons were selectively vulnerable to acidotoxicity
in vitro
, and that acidotoxicity was partially reduced in
asic1a
-deficient motoneuron cultures. Cross-breeding of
SOD1
G93A
ALS mice with
asic1a
-deficient mice delayed the onset and progression of motor dysfunction in
SOD1
mice. Interestingly, we also noted a strong increase in ASIC2 expression in motoneurons of
SOD1
mice and sporadic ALS patients during disease progression. Pharmacological pan-inhibition of ASIC channels with the lipophilic amiloride derivative, 5-(
N,N
-dimethyl)-amiloride hydrochloride, potently protected cultured motoneurons against acidotoxicity, and, given post-symptom onset, significantly improved lifespan, motor performance
and
motoneuron survival in
SOD1
mice. Together, our data provide strong evidence for the involvement of acidotoxicity and ASIC channels in motoneuron degeneration, and highlight the potential of ASIC inhibitors as a new treatment approach for ALS. |
---|---|
ISSN: | 1350-9047 1476-5403 |
DOI: | 10.1038/cdd.2012.158 |